TheFly.com
Start Free Trial
<
Back to all Breaking News
NK
6/3/2019 14:06pm
4
Street Research Stories
2
Calendar Events
chevron_right
NantKwest launches Phase 1 trial of CD19 t-haNK cell therapy in lymphoma
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
Join Now
Learn More
Already have an account?
Sign In Here
Subscription Rates
dynamic_feed
Breaking News
search
Search
menu
Menu